David T. Paik is the Senior Vice President at Mirae Asset Capital Life Science, where he specializes in venture investments in biotech companies. His focus is on novel therapeutics in areas like oncology and immunology, leveraging his scientific background which includes a Ph. D. from Vanderbilt University and postdoctoral research at Stanford University.
No publicly available information was found regarding Davids personal hobbies or non-work-related activities. His background is deeply rooted in academic and clinical cardiovascular research, which appears to be his primary focus outside of his investment role.
He is a recipient of the prestigious K99/R00 Pathway to Independence Award from the NIH for his research, highlighting his significant contributions to cardiovascular science.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.